Evidence map›Paper›PMID 32614340›Full record

ArticleLab on a chip2020

Micro-strains in the extracellular matrix induce angiogenesis.

Mary Kathryn Sewell-Loftin, Joshua B Katz, Steven C George, Gregory D Longmore

Open access · hybridAbstract read
In one paragraph

Article in Lab on a chip, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
2.0field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 28 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. A hitchhiker's guide to cancer models.Trends in biotechnology · 2022
    Review
  14. Review
  15. Article
  16. Review
  17. Article
  18. Review
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Mary Kathryn Sewell-LoftinDepartment of Biomedical Engineering, Wallace Tumor Institute, University of Alabama at Birmingham, 1824 6th Avenue South, Room 630A, Birmingham, AL 35294, USA. mksewellloftin@uab.edu.
Joshua B Katz
Steven C George
Gregory D Longmore
Washington University in St. Louis · USUniversity of California, Davis · US

Funding

The Role of Physical Cues in Collective Cell InvasionU54CA210173 · NCI · JOHNS HOPKINS UNIVERSITY · PI WIRTZ, DENIS · 2016 to 2020
$9.9M
Tumor stromal effects of DDR2 in metastasis regulationR01CA223758 · NCI · WASHINGTON UNIVERSITY · PI LONGMORE, GREGORY D. · 2018 to 2022
$1.9M
NOVEL SMALL MOLECULE INHIBITION OF DDR2 TO PREVENT BREAST CANCER METASTASISR01CA196205 · NCI · WASHINGTON UNIVERSITY · PI LONGMORE, GREGORY D. · 2015 to 2019
$1.7M
A 3-D In Vitro Platform of Tumor Metastasis (PQ24)R01CA170879 · NCI · WASHINGTON UNIVERSITY · PI GEORGE, STEVEN CARL · 2012 to 2015
$1.3M
Biomechanical Regulation of Angiogenesis during Tumor ProgressionR00CA230202 · NCI · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI SEWELL-LOFTIN, MARY KATHRYN · 2020 to 2022
$705k
Biomechanical Regulation of Angiogenesis during Tumor ProgressionK99CA230202 · NCI · WASHINGTON UNIVERSITY · PI SEWELL-LOFTIN, MARY KATHRYN · 2018 to 2019
$182k
NCI NIH HHS K99 CA230202NCI NIH HHS R00 CA230202NCI NIH HHS R01 CA170879NCI NIH HHS R01 CA196205NCI NIH HHS R01 CA223758NCI NIH HHS U54 CA210173
6 · The paper itself

Abstract

An improved understanding of biomechanical factors that control tumor development, including angiogenesis, could explain why few of the promising treatment strategies discovered via in vitro models translate well into in vivo or clinical studies. The ability to manipulate and in real-time study the multiple independent biomechanical properties on cellular activity has been limited, primarily due to limitations in traditional in vitro platforms or the inability to manipulate such factors in vivo. We present a novel microfluidic platform that mimics the vascularized tumor microenvironment with independent control of interstitial flow and mechanical strain. The microtissue platform design isolates mechanically-stimulated angiogenesis in the tumor microenvironment, by manipulating interstitial flow to eliminate soluble factors that could drive blood vessel growth. Our studies demonstrate that enhanced mechanical strain induced by cancer-associated fibroblasts (CAFs) promotes angiogenesis in microvasculature models, even when preventing diffusion of soluble factors to the growing vasculature. Moreover, small but significant decreases in micro-strains induced by inhibited CAFs were sufficient to reduce angiogenesis. Ultimately, we believe this platform represents a significant advancement in the ability to investigate biomechanical signals while controlling for biochemical signals, with a potential to be utilized in fields beyond cancer research.

Indexed as

NeoplasmsNeovascularization, PathologicNeovascularization, PhysiologicExtracellular MatrixHumansMicrofluidicsTumor Microenvironment

Identifiers

PMID32614340
PMCPMC7659465
OpenAlexW3038962487

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.